Research Article
Comparison of Cell Proliferation, Protein, and Glucose Metabolism in Musculoskeletal Tumors in a PET Study
Table 1
Patient characteristics and results of PET studies.
| Patient no. | Age | Sex | Histological diagnosis | Grade | Location | Lesion size (mm) | Choline | FAMT | FDG | Visual | SUV | Visual | SUV | Visual | SUV |
| Benign | | | | | | | | | | | | | 1 | 44 | F | Xanthofibroma | — | Tibia | 40 × 40 × 40 | ++ | 4.90 | ++ | 1.10 | ++ | 3.30 | 2 | 51 | F | Enchondroma | — | Scapular | 27 × 30 × 60 | + | 0.75 | + | 0.72 | + | 0.70 | 3 | 50 | M | No definite residual tumor cells | — | Knee | 50 × 50 × 50 | ++ | 0.98 | ++ | 1.24 | ++ | 1.74 | 4 | 58 | M | Schwannoma | — | Thigh | 35 × 35 × 35 | ++ | 1.80 | + | 0.71 | ++ | 1.70 | 5 | 59 | F | Bursitis with synovitis | — | Knee | 20 × 20 × 20 | ++ | 1.13 | — | — | + | 0.60 | 6 | 15 | F | Eosinophilic granuloma | — | Eosinophilic | 30 × 30 × 55 | ++ | 2.20 | ++ | 0.90 | ++ | 2.69 | 7 | 57 | M | Fibroma | — | Scapula | 30 × 30 × 50 | + | 0.62 | ++ | 1.70 | ++ | 1.53 | 8 | 62 | F | Schwannoma | — | Carpal | 5 × 9 × 10 | ++ | 1.50 | ++ | 0.91 | ++ | 1.80 | 9 | 60 | M | Neurofibroma | — | Femur | 50 × 60 × 150 | ++ | 5.10 | ++ | 1.40 | ++ | 3.49 | 10 | 53 | M | Giant cell tumor | — | Knee | 35 × 35 × 35 | ++ | 4.20 | + | 0.65 | ++ | 4.36 | 11 | 53 | M | Degeneration of skeletal muscle | — | Lower leg | 27 × 30 × 60 | ++ | 0.90 | + | 0.74 | + | 0.60 | 12 | 26 | F | Giant cell tumor | — | Femur | 28 × 31 × 42 | ++ | 8.00 | ++ | 1.10 | ++ | 8.39 | 13 | 15 | F | Desmoid tumor | — | Lower leg | 40 × 60 × 70 | ++ | 3.30 | + | 0.76 | ++ | 2.20 | 14 | 27 | F | Giant cell tumor | — | Knee | 30 × 30 × 40 | ++ | 1.12 | + | 0.71 | ++ | 3.23 | 15 | 48 | M | Desmoid tumor | — | Carpal | 30 × 40 × 60 | ++ | 3.10 | ++ | 1.00 | ++ | 2.77 | 16 | 61 | M | Desmoid tumor | — | Back | 40 × 40 × 70 | ++ | 2.30 | ++ | 1.17 | ++ | 2.14 | 17 | 55 | M | Lymphangioma | — | Knee | 30 × 40 × 50 | ++ | 1.69 | ++ | 0.92 | ++ | 1.37 | 18 | 51 | M | Lymphangioma | — | Axilla | 30 × 40 × 50 | ++ | 1.70 | ++ | 1.26 | ++ | 2.10 | 19 | 31 | M | Schwannoma | — | Lower leg | 10 × 20 × 30 | ++ | 0.88 | + | 0.56 | ++ | 0.81 | 20 | 47 | M | Desmoid tumor | — | Thigh | 65 × 46 × 68 | ++ | 2.46 | ++ | 1.64 | ++ | 3.27 | 21 | 58 | M | Aseptic necrosis | — | Talus | 30 × 30 × 30 | ++ | 2.40 | ++ | 1.20 | ++ | 1.74 | 22 | 20 | M | Pigmented villonodular synovitis | — | Poples | 30 × 30 × 50 | ++ | 2.69 | ++ | 0.86 | ++ | 2.60 | 23 | 53 | F | Degenerative joint disease | — | Femur | 40 × 70 × 110 | ++ | 2.24 | + | 0.58 | ++ | 2.40 |
| Malignant | | | | | | | | | | | | | 24 | 47 | M | Liposarcoma | 1 | Thigh | 70 × 70 × 120 | ++ | 0.82 | — | — | + | 0.61 | 25 | 43 | F | Osteosarcoma | 2 | Tibia | 20 × 24 × 55 | ++ | 9.30 | ++ | 2.00 | ++ | 6.00 | 26 | 53 | F | Malignant lymphoma | 3 | Clavicle | 27 × 28 × 30 | ++ | 4.50 | ++ | 0.91 | ++ | 4.90 | 27 | 17 | M | Ewing’s sarcoma | 3 | Femur | 54 × 50 × 150 | ++ | 2.60 | + | 0.58 | ++ | 0.89 | 28 | 54 | F | Metastatic carcinoma | 3 | Carpal | 50 × 50 × 60 | ++ | 9.00 | ++ | 1.06 | ++ | 3.19 | 29 | 83 | F | Malignant lymphoma | 3 | Femur | 50 × 80 × 196 | ++ | 7.30 | ++ | 7.00 | ++ | 14.49 | 30 | 12 | M | Osteosarcoma | 3 | Femur | 50 × 50 × 60 | ++ | 6.40 | ++ | 2.62 | ++ | 3.15 | 31 | 14 | F | Osteosarcoma | 3 | Femur | 60 × 70 × 160 | ++ | 4.12 | ++ | 1.27 | ++ | 13.66 | 32 | 11 | M | Osteosarcoma | 3 | Femur | 60 × 70 × 170 | ++ | 3.68 | ++ | 2.12 | ++ | 4.90 | 33 | 12 | M | Osteosarcoma | 3 | Femur | 50 × 100 × 140 | ++ | 3.03 | ++ | 1.38 | ++ | 5.37 | 34 | 64 | M | Myeloma | 3 | Sacrum | 40 × 51 × 60 | ++ | 3.60 | ++ | 1.80 | ++ | 2.55 | 35 | 84 | M | Liposarcoma | 3 | Femur | 230 × 280 × 360 | ++ | 3.20 | — | 0.30 | ++ | 6.00 | 36 | 44 | M | Metastatic carcinoma | 3 | Femur | 11 × 22 × 40 | ++ | 5.10 | ++ | 1.90 | ++ | 1.90 |
|
|